ZoetisBSP:Z1TS34 +1.96%70 OCF Margin % is 17.73% as of Mar. 2026, which is 38% below its 10-year median of 28.57. GuruFocus rates BSP:Z1TS34 with a GF Score™ of 70/100 and a GF Value™ of R$62.89 (Significantly Undervalued). Among 959 Drug Manufacturers companies, Zoetis ranks better than 92.39% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Zoetis's Cash Flow from Operations for the
three
months ended in Mar. 2026 was R$2,097 Mil. Zoetis's Revenue for the
three
months ended in Mar. 2026 was R$11,829 Mil. Therefore, Zoetis's OCF Margin % for the quarter that ended in Mar. 2026 was 17.73%.
The historical rank and industry rank for Zoetis's OCF Margin % or its related term are showing as below:
BSP:Z1TS34'
s OCF Margin % Range Over the Past 10 Years
Min: 14.59 Med: 28.57 Max: 31.9
Current: 29.39
During the past 13 years, the highest OCF Margin % of Zoetis was 31.90%. The lowest was 14.59%. And the median was 28.57%.
BSP:Z1TS34's OCF Margin % is ranked better than 92.39% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs BSP:Z1TS34: 29.39
Zoetis OCF Margin % Related Terms
Zoetis OCF Margin % Historical Data
* Premium members only.
The historical data trend for Zoetis's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:Z1TS34 vs UTHR, VTRS, NBIX: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zoetis OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zoetis's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Zoetis's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zoetis (BSP:Z1TS34) has a OCF Margin % of 17.73% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zoetis and its competitors. This is 38% below median its historical median of 28.57. Over the past decade, Zoetis' OCF Margin % has ranged from 14.59 to 31.90. According to the industry distribution chart, Zoetis ranks #73 out of 959 companies in the Drug Manufacturers industry, placing it in the top 7.6%.
Is Zoetis' OCF Margin % too high?
Zoetis' current OCF Margin % of 17.73% is 38% below median its 10-year median of 28.57. Over the past 10 years, this metric has ranged from a low of 14.59 to a high of 31.90. The Drug Manufacturers industry median OCF Margin % is 9.95. Zoetis' value of 17.73% is 78.2% above this industry median. Based on the distribution chart, Zoetis ranks #73 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zoetis has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zoetis' OCF Margin % compare to UTHR and VTRS?
According to the Drug Manufacturers industry distribution chart, Zoetis ranks #73 out of 959 companies for OCF Margin %. This places Zoetis in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Zoetis' value of 17.73% is 78.2% above this benchmark. Historically, Zoetis' own OCF Margin % has ranged from 14.59 to 31.90 over the past decade. While the company's 10-year median is 28.57 vs. the industry median of 9.95, Zoetis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zoetis's current OCF Margin % of 17.73% is 78.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zoetis and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zoetis's current OCF Margin % is 17.73%, which is 38% below median its own 10-year median of 28.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zoetis stock overvalued right now?
Based on GuruFocus' analysis, Zoetis (BSP:Z1TS34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$62.89, compared to a current price of R$24.93 — trading 60.4% below its estimated fair value. The current OCF Margin % is 17.73%, which is 38% below median its 10-year median of 28.57 and 78.2% above the Drug Manufacturers industry median of 9.95. Zoetis' overall GF Score™ is 70/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Zoetis (BSP:Z1TS34), the current OCF Margin % is 17.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zoetis (BSP:Z1TS34) Overvalued in 2026?
Based on GuruFocus' analysis, Zoetis stock appears to be undervalued.
The current stock price of R$24.93 is trading 60.4% below its estimated GF Value™ of R$62.89.
GuruFocus considers Zoetis to be Significantly Undervalued.
Key valuation signals for BSP:Z1TS34:
OCF Margin %: 17.73% (38% below median its 10-year median of 28.57)
GF Value™: R$62.89 vs. price of R$24.93 (60.4% below fair value)
Industry Position: 78.2% above the Drug Manufacturers median (#73 of 959)
No single metric tells the full story. See the BSP:Z1TS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
70GF Score
Get the complete analysis for BSP:Z1TS34
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:Z1TS34 has been successfully added to your 
